newsfilter
← Interviews
Bloomberg Television9 min

CVS Has Not Received Offers For the Retail Pharmacy Business, CEO Says

David Joyner

Interview

CVS Health executives are proceeding with a strategic spinoff of its retail pharmacy division from the parent corporation to optimize focus on value-based care and specialty services while the standalone retail entity targets growth in standard medication sales. The separation allocates approximately $60 billion in debt between the two newly independent companies, which management expects will both sustain investment-grade credit ratings without aggressive leverage. CEO David Joyner emphasized that despite external regulatory pressures to break up healthcare conglomerates, the restructuring aims to enhance consumer service capabilities and capital flexibility for both future entities.